本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sunshine Biopharma Inc.

0.3500
-0.0800-18.60%
成交量:526.70萬
成交額:194.49萬
市值:150.86萬
市盈率:-0.03
高:0.4022
開:0.4012
低:0.3462
收:0.4300
52周最高:24.30
52周最低:0.3462
股本:431.03萬
流通股本:404.18萬
量比:0.12
換手率:130.31%
股息:- -
股息率:- -
每股收益(TTM):-10.0329
每股收益(LYR):-14.3739
淨資產收益率:-21.92%
總資產收益率:-9.91%
市淨率:0.05
市盈率(LYR):-0.02

資料載入中...

2026/10/05

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/10/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/09/16

重要事件披露

Form 8-K - Current report
2026/09/11

重要事件披露

Form 8-K - Current report
2026/08/28

重要事件披露

Form 8-K - Current report
2026/08/28

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/20

重要事件披露

Form 8-K - Current report
2026/07/10

重要事件披露

Form 8-K - Current report
2026/07/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/22

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/22

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/18

SEC問詢函

Form CORRESP - Correspondence
2026/05/18

SEC問詢函

Form CORRESP - Correspondence
2026/05/15

SEC問詢函

Form CORRESP - Correspondence